The German Business Report
SEE OTHER BRANDS

Following business and economy news from Germany

Iran Insists on Uranium Enrichment, Sanctions Relief in U.S. Talks

(MENAFN) In a statement on Monday, Iran's Foreign Ministry spokesman Esmaeil Baghaei emphasized that the country’s demands for uranium enrichment and the complete lifting of sanctions are non-negotiable in ongoing indirect discussions with Washington.

Addressing the media at a weekly briefing in Tehran, Baghaei outlined Iran's position in the talks mediated by Oman, which have included three rounds so far: two in Muscat on April 12 and 26, and another in Rome on April 19.

He explained that any potential agreement must align with the framework previously established between the two sides, stating, "Thus, no agreement will be reached unless Iran's desired general framework is taken into account."

Baghaei also pointed out that technical consultations would occur at each stage of the negotiations.

The spokesman highlighted that "ending the sanctions effectively is a keyword" for Iran, stressing that access to the nation's "illegally and unjustly" frozen assets is one of the country's primary objectives in the talks.

Additionally, Baghaei mentioned that a delegation from the International Atomic Energy Agency (IAEA) had arrived in Tehran earlier on Monday to conduct technical discussions with Iranian officials on various issues, including safeguards.

MENAFN29042025000045017169ID1109484411


Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service